Viscoelastic Point-Of-Care Testing to Guide Transfusion and Antithrombotic Therapy in Perioperative and Critically Ill Patients: Are All Parameters Created Equal?
Free accessEditorialFirst published online January, 2016
Viscoelastic Point-Of-Care Testing to Guide Transfusion and Antithrombotic Therapy in Perioperative and Critically Ill Patients: Are All Parameters Created Equal?
GibbsN.M.Hypocoagulability, hypercoagulability and the interpretation of ‘normal’ kaolin-activated thrombelastographs in the perioperative period. Anaesth Intensive Care2011; 39: 802–803.
2.
WhitingP., AlM., WestwoodM., RamosI.C., RyderS., ArmstrongN.Viscoelastic point-of-care testing to assist with the diagnosis, management and monitoring of haemostasis: a systematic review and cost-effectiveness analysis. Health Technol Assess2015; 19: 1–228.
3.
HaasT., SpielmannN., RestinT., SeifertB., HenzeG., ObwegeserJ.Higher fibrinogen concentrations for reduction of transfusion requirements during major paediatric surgery: A prospective randomised controlled trial. Br J Anaesth2015; 115: 234–243.
4.
DuffO.C., HoK.M., MaybrookS.In-vitro thrombotic tendency of reactive thrombocytosis in critically ill patients: a prospective case-control study. Anaesth Intensive Care2012; 40: 472–478.
5.
HinckerA., FeitJ., SladenR.N., WagenerG.Rotational thromboelastometry predicts thromboembolic complications after major non-cardiac surgery. Crit Care2014; 18: 549.
6.
McCrathD.J., CerboniE., FrumentoR.J., HirshA.L., Bennett-GuerreroE.Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction. Anesth Analg2005; 100: 1576–1583.
7.
ZmudaK., NeofotistosD., Ts'aoC.H.Effects of unfractionated heparin, low-molecular-weight heparin, and heparinoid on thromboelastographic assay of blood coagulation. Am J Clin Pathol2000; 113: 725–731.
8.
LevinA.I., HeineA.M., CoetzeeJ.F., CoetzeeA.Heparinase thromboelastography compared with activated coagulation time for protamine titration after cardiopulmonary bypass. J Cardiothorac Vasc Anesth2014; 28: 224–229.
9.
PrakashS., WiersemaU.F., BihariS., RoxbyD.Discordance between ROTEM® clotting time and conventional tests during unfractionated heparin based anticoagulation in intensive care patients on extracorporeal membrane oxygenation. Anaesth Intensive Care2016; 44: 85–92.
10.
HagemoJ.S., StanworthS., JuffermansN.P., BrohiK., CohenM., JohanssonP.I.Prevalence, predictors and outcome of hypofibrinogenaemia in trauma: a multicentre observational study. Crit Care2014; 18: R52.
11.
HoK.M., DuffO.C.Predictors of an increased in vitro thrombotic and bleeding tendency in critically ill trauma and non-trauma patients. Anaesth Intensive Care2015; 43: 317–322.
12.
SolomonC., Rahe-MeyerN.Fibrinogen concentrate as first-line therapy in aortic surgery reduces transfusion requirements in patients with platelet counts over or under 100×10(9)/L. Blood Transfus2015; 13: 248–254.
13.
MiaoX., LiuJ., ZhaoM., CuiY., FengZ., ZhaoJ.The influence of cardiopulmonary bypass priming without FFP on postoperative coagulation and recovery in pediatric patients with cyanotic congenital heart disease. Eur J Pediatr2014; 173: 1437–1443.
14.
ToukhM., SiemensD.R., BlackA., RobbS., LeveridgeM., GrahamC.H.Thromboelastography identifies hypercoagulablilty and predicts thromboembolic complications in patients with prostate cancer. Thromb Res2014; 133: 88–95.
15.
RoeloffzenW.W., Kluin-NelemansH.C., MulderA.B., VeegerN.J., BosmanL., de WolfJ.T.In normal controls, both age and gender affect coagulability as measured by thrombelastography. Anesth Analg2010; 110: 987–994.
16.
KiliçY., TopçuI., BambalH., CiviM.Thromboelastography in the evaluation of coagulation disorders in patients with sepsis. Turk J Med Sci2014; 44: 267–272.
17.
DurilaM., BuresJ., PelichovskáM., CvavhovecK.Hypocoagulation state in severe systemic inflammatory response syndrome/sepsis is consistent with endogenous heparinoid effect as detected by thromboelastography. Anaesth Intensive Care2011; 39: 508–509.
18.
SenzoloM., AgarwalS., ZappoliP., VibhakornS., MallettS., BurroughsA.K.Heparin-like effect contributes to the coagulopathy in patients with acute liver failure undergoing liver transplantation. Liver Int2009; 29: 754–759.
19.
MatzelleS.J., GibbsN.M., WeightmanW., SheminantM., RoweR., BakerS.Systemic anticoagulant effect of low-dose subcutaneous unfractionated heparin as determined using thrombelastography. Anaesth Intensive Care2007; 35: 498–504.
20.
HeilmannC., GeisenU., BeyersdorfF., NakamuraL., BenkC., TrummerG.Acquired von Willebrand syndrome in patients with extracorporeal life support (ECLS). Intensive Care Med2012; 38: 62–68.
21.
LangT., von DepkaM.Possibilities and limitations of thromboelastometry/-graphy. Hamostaseologie2006; 26: S20–S29.
22.
LouisS.G., VanP.Y., RihaG.M., BartonJ.S., KunioN.R., UnderwoodS.J.Thromboelastogram-guided enoxaparin dosing does not confer protection from deep venous thrombosis: a randomized controlled pilot trial. J Trauma Acute Care Surg2014; 76: 937–942.
23.
AdelmannD., WiegeleM., WohlgemuthR.K., KochS., FrantalS., QuehenbergerP.Measuring the activity of apixaban and rivaroxaban with rotational thrombelastometry. Thromb Res2014; 134: 918–923.